in silico methods in fragment-based drug design — a Protein Kinase B case study

webinar

Wed, 28 Jan 2015, 19:00 CET (Berlin)

Dr. Alastair Donald, BioSolveIT GmbH, St. Augustin, Germany

in silico methods in fragment-based drug design — a Protein Kinase B case study

Computational tools are invaluable in the process of identifying high-quality fragment hits. In this one hour BioSolveIT webinar you will learn how to fast-track your fragment hit discovery using our cutting edge in silico solutions using Protein Kinase B as an example.

By the end you will appreciate how our suite of SBDD tools can enrich your work life, enhance your productivity and assist in the identification of potent, selective and synthetically accessible lead-like molecules.

So, if you are interested in

  • enriching your screening collection with potent and selective fragments
  • intelligently selecting which commercially available analogs to purchase
  • deciding which analogs to prioritize for synthesis
  • saving time and money by focusing on the most promising ideas

watch the video live recording below.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on